Literature DB >> 1721010

Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL)

N R Ling1, F K Stevenson, B Brown.   

Abstract

A soluble form of CD23 (sCD23) was found in the urine from 12 normal individuals but was not present in 20 normal sera, suggesting that sCD23 produced by cells in tissues is eliminated in the urine. The sCD23 from urine differed in physicochemical properties from the sCD23 found in supernates from B-lymphoblastoid cell lines (B-LCL) and in the sera of patients with B type chronic lymphocytic leukaemia (B-CLL). On SDS-PAGE analysis under reducing conditions urinary sCD23 showed two bands corresponding to molecular weights of 45-60 kD and 28-35 kD indicating that sCD23 may be excreted in combination with another molecule. When subjected to gel filtration in its native state, sCD23 from urine showed a major peak at approximately 150 kD and a minor peak (probably a breakdown product) at 21 kD. Urinary sCD23 was more strongly held by DEAE-cellulose and required 0.5 M buffer pH 8.0 for elution, suggesting that it is more anionic than sCD23 from culture supernates. Five MoAbs recognizing different epitopes on sCD23 from B-LCL supernates were tested on urinary sCD23. Four of the MoAbs were reactive but one (EBVCS-1) was not. Urinary sCD23 did not bind to IgE. The level of sCD23 found in normal urine (approximately 0.02-0.05 micrograms/ml) was exceeded in 17 of 24 cases of B-CLL. In one case with a high cell count and a serum concentration of 10 micrograms/ml, the urine contained 80 micrograms/ml sCD23. In another case a high serum sCD23 was not matched by a high urinary level. In this case the gel filtration pattern was closer to that found with urine sCD23 rather than the B-LCL pattern found with sera of other B-CLL patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721010      PMCID: PMC1554202          DOI: 10.1111/j.1365-2249.1991.tb02938.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia.

Authors:  M Sarfati; D Bron; L Lagneaux; C Fonteyn; H Frost; G Delespesse
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

2.  Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins.

Authors:  N R Ling; S Bishop
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

3.  Purification and partial biochemical characterization of IgE-binding factors secreted by a human B lymphoblastoid cell line.

Authors:  M Sarfati; T Nakajima; H Frost; E Kilccherr; G Delespesse
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

4.  A hapten-specific chimaeric IgE antibody with human physiological effector function.

Authors:  M S Neuberger; G T Williams; E B Mitchell; S S Jouhal; J G Flanagan; T H Rabbitts
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

5.  A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues.

Authors:  N R Ling; D Hardie; J Lowe; G D Johnson; M Khan; I C MacLennan
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

6.  Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL).

Authors:  L Marcon; M E Fritz; C C Kurman; J C Jensen; D L Nelson
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

7.  Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia.

Authors:  N Ling; T Hansel; P Richardson; B Brown
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

8.  Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.

Authors:  J Y Bonnefoy; T Defrance; C Peronne; C Menetrier; F Rousset; J Pène; J E De Vries; J Banchereau
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

9.  The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens.

Authors:  J Y Bonnefoy; O Guillot; H Spits; D Blanchard; K Ishizaka; J Banchereau
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

10.  Soluble cytokine receptors are present in normal human urine.

Authors:  D Novick; H Engelmann; D Wallach; M Rubinstein
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  3 in total

1.  Origin and properties of soluble CD21 (CR2) in human blood.

Authors:  N R Ling; D L Hardie; G D Johnson; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

2.  Pitfalls in the measurement of soluble forms of cell surface receptors.

Authors:  N R Ling
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

3.  Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases.

Authors:  A Yokoyama; N Kohno; Y Hirasawa; K Kondo; M Abe; Y Inoue; S Fujioka; S Fujino; S Ishida; K Hiwada
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.